Memory retrieval improvement by Heteropterys aphrodisiaca in aging rats by Galvao, Suzana Maria Pereira et al.
*Correspondence: S.M.P. Galvão. Centro de Ciências da Saúde, Universidade 
Estadual do Piauí. Rua Olavo Bilac, 2335, 64001-280 - Teresina – PI, Brazil. 
E-mail: smpgalvao@gmail.com
A
rt
ic
leBrazilian Journal of 
Pharmaceutical Sciences
vol. 47, n. 4, oct./dec., 2011
Memory retrieval improvement by Heteropterys aphrodisiaca  
in aging rats
Suzana Maria Pereira Galvão1*, Fúlvio Rieli Mendes2, Maria Gabriela Menezes de Oliveira3,  
Rita Mattei3, João Carlos Palazzo de Mello4, Walter Antonio Roman Júnior5,  
Elisaldo de Araújo Carlini3
1Center for Health Sciences, Universidade Estadual do Piauí, 2Center of Natural Sciences and Humanities, Universidade 
Federal do ABC, 3Department of Psychobiology, Universidade Federal de São Paulo, 4 Department of Pharmacy, Universidade 
Estadual de Maringá, 5Laboratory of Pharmacognosy, Universidade Comunitária Regional de Chapecó
Few data exists about the pharmacological properties of Heteropterys aphrodisiaca O. Mach. 
(Malpighiaceae), which is native to the scrubland regions of Brazil. The present study investigated the 
effects of oral treatment with H. aphrodisiaca extract (BST0298) on the learning and memory of young 
(3-6 months) and aged (21-23 months) rats, and compared the in vitro antioxidant activity of three lots 
collected in different years. An improvement in the number of sessions to learn the task was observed in 
the left/right discrimination test in aged rats treated for 45 days with 25 mg/kg (7.0 ± 0.5; p=0.005) or 50 
mg/kg (7.6 ± 0.6; p=0.012) compared with control old rats (11.0 ± 1.6). On the other hand, pre-treatment 
did not improve the performance of scopolamine-treated mice in the passive avoidance test. The in vitro 
malondialdehyde test showed that all three different extracts presented similar antioxidant activity. The 
flavonoids astilbin, isoastilbin and neoastilbin were isolated from the extract and may contribute to the 
biological activity. These results suggest that repeated treatment with H. aphrodisiaca improves learning 
and memory, probably by a non-muscarinic mechanism.
Uniterms: Heteropterys aphrodisiaca O. Mach/pharmacognosy. Heteropterys aphrodisiaca O. Mach/
antioxidant activity. Malpighiaceae/pharmacognosy. Antioxidants. Flavonoids. Plant extract. 
Existem poucos dados disponíveis sobre as propriedades farmacológicas da Heteropterys aphrodisiaca 
O. Mach. (Malpighiaceae), nativa da região do pantanal brasileiro. O presente estudo investigou o efeito 
do tratamento oral com um extrato de H. aphrodisiaca (BST0298) sobre a memória e aprendizagem 
de ratos jovens (3-6 meses) e idosos (21-23 meses) e comparou a atividade antioxidante in vitro de três 
lotes, coletados em diferentes anos. Melhora quanto ao número de sessões necessárias para aprender a 
tarefa foi observada no teste de discriminação direita/esquerda em ratos idosos tratados por 45 dias com 
doses de 25 mg/kg (7,0 ± 0,5; p=0,005) e 50 mg/kg (7,6 ± 0,6; p=0,012) comparados com ratos idosos 
controle (11,0 ± 1,6). Por outro lado, o pré-tratamento com o extrato não melhorou o desempenho de 
camundongos tratados com escopolamina no teste da esquiva passiva. Em relação à avaliação da atividade 
antioxidante in vitro pelo teste do malonodialdeído, os três lotes analisados apresentaram atividade 
antioxidante semelhante. Os flavonóides astilbina, isoastilbina e neoastilbina foram isolados do extrato 
e podem contribuir para a atividade biológica. Estes resultados sugerem que a administração repetida de 
H. aphrodisiaca melhora a memória e aprendizagem provavelmente por um mecanismo não muscarínico.
Unitermos: Heteropterys aphrodisiaca O. Mach/farmacognosia. Heteropterys aphrodisiaca O. Mach/
atividade antioxidante. Malpighiaceae/farmacognosia. Antioxidantes. Flavonóides. Extrato vegetal.
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INTRODUCTION
Heteropterys aphrodisiaca O. Mach. (Malpighia-
ceae) is a Brazilian plant whose roots in “cachaça” (an 
alcoholic drink) are used as an aphrodisiac, tonic or stimu-
lant, as well as for nervous debility (Corrêa, 1984; Pott, 
Pott, 1994). It is mainly found in the scrubland regions 
of the Brazilian states of Mato Grosso and Goiás (Cor-
rêa, 1984), and is known as “nó-de-cachorro” (Pott, Pott, 
1994). H. aphrodisiaca and other plants considered tonics 
by the general population are taken chronically – as are 
adaptogenic plants – with the aim of improving general 
health and for their preventive effect in relation to a wide 
range of health problems (Mendes, Carlini, 2007).
Various studies have shown that adaptogenic plants 
affect the nervous system, improving cognitive functions 
by slowing down the deterioration of cognitive processes 
observed in elderly people. For instance, Panax ginseng 
C.A. Mey. (Araliaceae), a classical adaptogenic plant, has 
been shown to restore the learning and memory deficits 
of aged rats evaluated in a two-way active avoidance test 
(Petkov, Belzheva, Petkov, 2003) and in an 8-arm radial 
maze (Nitta et al., 1995). It has also been shown to restore 
impaired acquisition of scopolamine and ethanol-treated 
rats in passive avoidance performance studies (Hsieh et 
al., 2000; Lee, Moon, You, 2000).
Our previous studies have shown that a hydroalco-
holic extract of H. aphrodisiaca (BST0298 extract) had a 
positive effect on memory in aged rats when evaluated in 
a passive avoidance test, after 7 or 26 days of treatment 
(dose of 100 mg/kg), and in a left/right discrimination test 
in a T-maze, after 109 days of treatment with 50 mg/kg 
(Galvão, 1997; Galvão et al., 2002). The extract BST0298 
also showed both in vitro and in vivo antioxidant effects 
(Mattei et al., 2001). On the other hand, acute treatment 
with the extract (100 mg/kg) had no effect on the passive 
avoidance test (Galvão et al., 2002).
It is important to determine the smallest active dose of 
a compound and the minimal time necessary to obtain the 
desired action, which can be useful to diminish the possibil-
ity of toxic effects. These data led us to investigate the ef-
fects of the extract BST0298, prepared from the roots of H. 
aphrodisiaca, on the memory and learning capacity of aged 
rats, to verify whether a smaller dose and a shorter period of 
treatment would also be efficient in these performance tests.
MATERIAL AND METHODS
Animals
We used 150 male Swiss albino mice, 3 months old, 
and 69 male Wistar rats, 3-6 months old (young) and 21-23 
months old (aged) at the beginning of the study, provided 
by the Department of Psychobiology, Universidade Fed-
eral de São Paulo. The animals were housed in standard 
polypropylene cages (30 × 38 cm sides; 17 cm high) in 
groups of five (rats) and twenty (mice), and kept in a room 
with a controlled temperature (23 ± 2 °C) and light-dark 
cycle (lights on from 7 a.m. to 7 p.m.). Food and water 
were freely available.
The procedures adopted were approved by the 
UNIFESP ethical committee (protocol number 295/00) 
and according to the norms recommended by the Inter-
national Guiding Principles for Biomedical Research 
involving Animals (CIOMS) – Geneva, 1985.
Plant material
Heteropterys aphrodisiaca O. Mach. roots were 
collected over a three-year period during the Brazilian 
autumn (March, 1996 – lot 1; April, 1998 – lot 2; April, 
1999 – lot 3) in Santo Antônio do Leverger, Mato Grosso 
State, Brazil (30º28’31’’S and 51º35’25’’W). The plants 
were identified by Dr. Miramy Macedo, and a voucher 
specimen was deposited in the herbarium at the Federal 
University of Mato Grosso (UFMT), Brazil, under number 
22,181. Lot 1 was investigated in our previous studies 
(Mattei et al., 2001; Galvão et al., 2002).
Drugs
Scopolamine hydrobromide and thiobarbituric acid 
were purchased from Sigma Chemical Company (St. 
Louis, MO, USA). Scopolamine was diluted in water. The 
plant extract was prepared by dissolving the lyophilized 
material in distilled water in such a volume as to admin-
ister orally (gavage) the desired dose in 0.1 mL per 100 g 
body weight for rats and 0.1 mL per 10 g for mice. Doses 
of 25 and 50 mg/kg were used for 45-day treatment (rats 
evaluated on the T maze), and 100, 200, and 400 mg/kg 
for shorter treatments (from 1 to 21 days; mice evaluated 
on the passive avoidance test).
Preparation of extract BST0298 and isolation of 
polyphenolic compounds
The roots of H. aphrodisiaca were crushed and 
powdered using a grinding mill. The standardized extract, 
designated BST0298, was prepared by turbo extraction 
as described by Voigt (1993), using a 50% water-ethanol 
solvent.
The lyophilized BST0298 extract (300 g) was redis-
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solved in 3,000 mL H2O and extracted with EtOAc (30 L). 
After evaporation of solvents, the EtOAc fraction and the 
remaining H2O phase gave dark-brown solids of 16.2 g and 
265.6 g, respectively. A portion (15 g) of EtOAc fraction 
was subjected to column chromatography on Sephadex 
LH-20 [710×50 mm; eluents: 50% EtOH, 100% EtOH, 
and 70% Me2CO; 10 mL fractions] afforded 10 subfrac-
tions (Roman Júnior, 2003).
Subfraction VI (251.5 mg) yielded a pure compound 
identified as isoastilbin [3-O-α-L-rhamnosyl-cis-(2R,3S)-
taxifolin] (40 mg) (1). Subfraction VII (2,300.6 mg) was 
purified through crystallization to yield the pure compound 
astilbin [3-O-α-L-rhamnosyl-trans-(2R,3R)-taxifolin] 
(120 mg) (2). Subfraction VIII (1,095.4 mg) was sub-
jected to CC on Sephadex LH-20 [320×35 mm; eluent: 
50% EtOH (2 L); 10 mL fractions] giving 3 subfractions 
(VIII-1, VIII-2, and VIII-3). Subfraction VIII-3 (240 mg) 
resulted in the pure compound neoastilbin [3-O-α-L-
rhamnosyl-trans-(2S,3S)-taxifolin] (3) (Figure 1).
All NMR spectra of the compounds (1-3) (1H, 13C, 
COSY, DEPT, HETCOR) were recorded in CD3OD on a 
Varian Mercury 300BB (300 MHz) at ambient temperature 
with TMS as the internal standard. CD data were obtained 
in MeOH on a Jasco J-815. ESI-MS mass spectrometer: 
Quattro LCZ, Firma Waters, was measured in the positive-
ion mode. Polarimetry was measured in a Perkin Elmer 
mod. 343. L-rhamnose was identified (TLC) after acid 
hydrolysis using the method described by Kartinig and 
Wegschaider (1971).
Left/right discrimination test
Rats were individually trained and tested in a T-
maze with arms 60 cm long by 10 cm wide and walls 3 cm 
high. The maze was raised 1 m above the floor. One piece 
of cereal, 150 mg of Froot Loops (Kellogg Brazil Ltda., 
São Paulo, Brazil), was placed at the end of each arm as 
reinforcement. The apparatus was placed in the center of 
a room which contained spatial cues and was cleaned with 
20% alcohol after each run to prevent olfactory cues during 
training. The procedure is described bellow.
Treatment of naïve rats for 45 days
Three groups of aged rats (n=18) were orally treated 
for 45 days with 25 and 50 mg/kg of BST0298 extract (lot 
3) or water (n=15). A young group of rats (n=10) received 
water.
On the 11th day of treatment, the animals started the 
learning phase in the T maze. The treatment was given in 
the morning and the training between 1:00 p.m. and 6:00 
p.m. The animals were placed individually in the maze 
for 5 min without the presence of reinforcement. This 
procedure was repeated on the 13th and 15th days.
On the 16th day, the reward was placed at the both 
ends of the maze arms and the animals, which had been 
starved for the preceding 20 hours, were placed individu-
ally in each arm for one minute. This procedure was per-
formed on alternate days and was repeated 6 more times.
On the 29th day, the training phase of the T maze left/
right discrimination test began with 50% of the rats from 
each group randomly selected and reinforcement placed in 
the right arm. For the other 50%, reinforcement was placed 
in the left arm. The reinforced arm (correct arm) remained 
constant throughout the training period. On alternate days 
the animals were subjected to training sessions, each of 
which was composed of six consecutive runs. Each run 
started with the animal being placed at the start-arm, and 
if it chose the correct side-arm, it received the reward. If 
the animal chose the incorrect side-arm, it was confined 
in the arm for 30 s without a reward. The animal was then 
placed at the start-arm for the next run. The time limit for 
the animal to enter one of the side-arms was 5 min. If it 
did not enter a side-arm in 5 min, it was confined in the 
incorrect side-arm for 30 s without a reward. The rats were 
trained until they achieved the learning criteria of at least 
two consecutive sessions without an error (12 correct runs) 
or until they had had 20 training sessions (the training 
ceiling) (Galvão et al., 2007).
FIGURE 1 - Isolated flavonoids of the extract of Heteropteris aphrodisiaca. (1) isoastilbin, (2) astilbin and (3) neoastilbin.
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Reversion of the amnesic effect of scopolamine in 
young mice
Acute treatment
Groups of 10 mice were acutely administered 
BST0298 extract (lot 2) orally in doses of 100, 200 or 
400 mg/kg or water (control group). Thirty minutes later, 
the mice received a scopolamine injection (0.5 mg/kg, i.p). 
A fifth group received water (orally) and, after 30 min, 
saline (i.p.) instead of scopolamine.
Thirty minutes after scopolamine or water ad-
ministration, the animals were evaluated in the passive 
avoidance apparatus (acquisition training). Each mouse 
was placed in the light compartment with the connecting 
door closed and after 10 s the door was opened and the 
time taken for the animal to cross into the dark compart-
ment was recorded. As soon as the animal entered the dark 
compartment the door was closed and one shock of 1.0 mA 
lasting 2 s was applied to the animal’s paw. Immediately 
afterwards, the animal was removed from the apparatus. 
The maximum time allowed for an animal to cross into the 
dark compartment was 180 s (Galvão et al., 2002).
7- and 21-day treatment
Four groups of 10 mice each were orally treated for 
7 days with water (controls) or the BST0298 extract (lot 
2) in doses of 100, 200 or 400 mg/kg. On the 8th treatment 
day, mice were administered scopolamine (0.5 mg/kg, 
i.p.) (or water for the controls) and were subjected to the 
passive avoidance test as described earlier. A fifth group 
received scopolamine but no extract.
The same procedure was carried out in mice treated 
for 21 days with the extract.
Antioxidant activity in vitro
In this study, lots 2 and 3 of the BST0298 extract were 
evaluated. Male rats were anesthetized with diethyl ether 
and the brains were perfused with 0.1 mol/L phosphate buf-
fer pH 7.4. The rats were then decapitated and the brains 
quickly excised for homogenization in the same buffer (1:4 
w/v). The homogenates were centrifuged at 3000 rpm for 15 
min (4 oC) and the pellets discarded. The cleared samples 
were used for evaluation of lipid peroxidation for 1 h at 
37 oC in the presence of different extract concentrations. 
Products of spontaneous lipid peroxidation react with thio-
barbituric acid to form a colored compound, the intensity of 
which is measured at 535 nm in a spectrophotometer (Stocks 
et al., 1974; Mattei et al., 2001). The concentration of the 
extract that inhibits 50% of peroxidation is referred to as 
Q1/2, and it was calculated after 3-5 assays.
Statistical analysis
The latency of entry into the dark box in the pas-
sive avoidance test with mice was analyzed using the 
Kruskal-Wallis test followed by the Mann-Whitney U 
test. The number of sessions required to achieve the 
learning criteria in the left/right discrimination task was 
analyzed using one-way analysis of variance (ANOVA) 
followed by Duncan’s post-hoc test. p ≤ 0.05 was con-
sidered to be statistically significant. The antioxidant 
activity was calculated using a linear regression method 
(GraphPad Prism®).
RESULTS
Left/right discrimination test
As can be seen in Figure 2, there were statisti-
cally significant differences between the groups [one way 
ANOVA: F(3,50)=4.294338; p=0.008]. Duncan’s post 
hoc test (p=0.005) showed that the rats of the aged control 
group needed a greater number of sessions (11.0±1.6) 
to achieve the learning criteria when compared with the 
young control group (7.1±0.6). The aged rats treated for 
45 days with 25 or 50 mg/kg of BST0298 extract showed 
similar performance to the young control rats (7.0±0.5, 
7.6±0.6, respectively) (Duncan: p=0.93 for 25 mg/kg; 
p=0.68 for 50 mg/kg), and clearly displayed a better per-
formance than the aged control rats (Duncan: p=0.005 for 
25 mg/kg; p=0.012 for 50 mg/kg).
FIGURE 2 - Number of sessions required to achieve the learning 
criteria in the T maze by young control rats (), aged control rats 
() and aged rats treated with 25 mg/kg () or 50 mg/kg () of 
Heteropterys aphrodisiaca extract (HA) for 45 days. The values 
are expressed as mean ± standard error. *Statistically different 
from the young control group (p<0.05). #Statistically different 
from the aged control group (p<0.05). 1-ANOVA followed by 
Duncan.
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TABLE I - Antioxidant activity in vitro (inhibition of 50% of spontaneous lipoperoxidation: Q1/2) of two lots of BST0298 extract 
from Heteropterys aphrodisiaca
Extract Year, month and 
season of collection
Temperature 
(mean; ºC)
Rainfall 
(mm)
No. of 
assays
Q1/2 (mg/mL) ± 
confidence interval
Lot 2 1998; April; autumna 33 143.8 5 3.9 ± 0.3
Lot 3 1999; April; autumna 32 12.8 3 3.6 ± 0.1
a in the Southern Hemisphere.
Reversion of the amnesic effect of scopolamine in 
young mice
Acute treatment
As shown in Figure 3, there were no statistically 
significant differences among the groups in the acquisition 
phase, as expected [Kruskal-Wallis: H=6.5788; p=0.16]. 
However, in the retention phase, statistically significant dif-
ferences were found between the groups [Kruskal-Wallis: 
H=19.8173; p=0.0005]. The scopolamine control group 
entered the dark compartment with a lower latency, in com-
parison to the control (no scopolamine) mice, demonstrating 
impairment in the passive avoidance test (Mann-Whitney: 
U=0.0; p=0.000094). Mice previously treated with the 
BST0298 extract (acutely) plus 0.5 mg/kg scopolamine 
did not present a reversal of scopolamine-induced memory 
impairment in the passive avoidance test, presenting similar 
behavior as animals receiving only scopolamine (Mann-
Whitney: U=36.5; p=0.30 for 100 mg/kg; U=32.0; p=0.17 
for: 200 mg/kg; U=34.0; p=0.22 for 400 mg/kg) (Figure 3).
7- and 21-day treatment
There were statistically significant differences be-
tween the groups in the retention phase on 7-day treatment 
[Kruskal-Wallis: H=15.1881; p=0.0043] and 21-day treat-
ment tests [Kruskal-Wallis: H=20.6927; p=0.0004]. The 
scopolamine control group was statistically different from 
the control (no scopolamine) group in the retention phase, 
both on 7-day (Mann-Whitney: U=0.0; p=0.000071) and 
21-day treatment (Mann-Whitney: U=0.0; p=0.00003), 
demonstrating impairment in the passive avoidance 
test. However, neither 7 nor 21-day treatment with the 
BST0298 extract reverted scopolamine-induced memory 
impairment in mice (data not shown).
Antioxidant activity
The antioxidant effect of the extract (lot 2 and lot 3) 
is indicated in Table I. An inhibition of 50% of spontane-
ous lipid peroxidation (Q1/2) can be observed for lot 2 
(3.9 ± 0.3 mg/mL) and lot 3 (3.6 ± 0.1 mg/mL), indicat-
ing that the plant collected during the same season but 
in different years maintained antioxidant activity within 
the same range, similar to that of lot 1 collected in 1996 
(Q1/2 = 3.3 mg/mL) (Mattei et al., 2001).
DISCUSSION
Many authors have studied the deterioration in 
learning and memory which occurs with aging and have 
correlated it to anatomical and biochemical alterations in 
the central nervous system. In this context, it is possible 
to study drugs that may reduce this deterioration or restore 
learning and impaired memory in old age.
Our results obtained with the T maze confirmed the 
positive effects of BST0298 extract. Previous studies have 
shown that old rats treated with 50 mg/kg of extract (lot 1) 
for 109 days achieved the learning criteria in a number 
of sessions practically equal to the number achieved by 
the young animals and faster than the old control animals 
(Galvão et al., 2002). In the present study, aged rats were 
FIGURE 3 - Latency for the acquisition and retention (24h later) 
phases of the passive avoidance test by control (no scopolamine) 
mice (), control mice treated acutely with water + 0.5 mg/kg 
of scopolamine ( ), and experimental mice treated with 
100 mg/kg (), 200 mg/kg () or 400 mg/kg () of the extract 
of Heteropterys aphrodisiaca + scopolamine 0.5 mg/kg. The 
values are expressed as medians + semi-interquartile ranges. 
*Statistically different from the control (no scopolamine) group 
(p<0.05). Kruskal-Wallis followed by Mann-Whitney.
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treated with smaller doses of the extract for a shorter pe-
riod. We observed a clear effect on learning performance 
in aged rats treated for 45 days with 25 and 50 mg/kg of lot 
3; the number of sessions to achieve the learning criteria 
was similar to that for young animals, and smaller than 
the number of sessions for aged controls (Figure 2). This 
study shows that BST0298 extract reverted the memory 
impairment observed in aged rats with a shorter treatment 
period and smaller doses than the previous study.
Several studies suggest that the cholinergic system 
is involved in the learning and memory process (Miranda 
et al., 2003; Hasselmo, 2006). Drugs which inhibit the 
metabolism of acetylcholine, such as physostigmine 
(Mukherjee et al., 2007), and direct cholinergic agonists, 
such as arecoline, oxotremorine, and bethanechol (Merlini, 
Pinza, 1989) have shown beneficial effects on memory 
in experimental studies. Anticholinesterase drugs, such 
as tacrine, donepezil, rivastigmine, and galantamine, are 
available for the treatment of Alzheimer disease (Per-
neczky, Kurz, 2004; Mukherjee et al., 2007). Muscarinic 
antagonists, such as scopolamine, are experimentally used 
as markers for the study of drugs that possibly modulate 
this neuronal system, since they cause performance im-
pairment in animals in several different memory tasks 
(Quirarte et al., 1994; Heo et al., 2006). Aiming to verify 
whether the extract of H. aphrodisiaca acts by a cholin-
ergic mechanism, we have evaluated its ability to prevent 
the amnesic effect of scopolamine in mice. In the passive 
avoidance test of the present study, no performance im-
provement was observed for animals with scopolamine-in-
duced amnesia treated with the BST0298 extract (acutely 
or for 7 or 21 days). Results for extract-treated animals 
were similar to those receiving only scopolamine, show-
ing that the chemical components of the extract probably 
are not muscarinic agonists. In addition, these animals 
did not display typical cholinergic side effects, such as 
tremors or chromodacryorrhea, which can be observed 
with cholinergic drugs (Espínola, Oliveira, Carlini, 1999).
It is unclear whether the effects of the H. aphro-
disiaca extract could be attributed to one or more of its 
chemical constituents, since preliminary assays revealed 
the presence of several compounds in the extract, such as 
flavonoid glycosides, cardiac glycosides with steroidal 
nuclei, aromatic glycosides with a five-membered lactone 
ring, saponins, hydrolysable and condensed tannins, and 
nitro compounds (Galvão, 1997; Galvão et al., 2002). The 
phytochemical characterization of the BST0298 extract 
employed in the present study showed the presence of 
flavonoids astilbin, neoastilbin, and isoastilbin, well char-
acterized (see Figure 1 and text in Material and Methods) 
and identified by HPLC, and an aliphatic nitro compound 
known as 2,3,4,6-tetra-O-(3-nitropropanoyl)-O-β-D-
glucopyranoside (Roman Júnior et al., 2005; Marques et 
al., 2007). However, no positive effect of these flavonoids 
on memory has been reported in the literature.
It is known that many plants protect against the 
effects of oxidative stress and that their antioxidant ca-
pacity is attributable to the presence of compounds such 
as flavonoids, tannins, and saponins (Packer, Hiramatsu, 
Yoshikawa, 1999; Ng, Liu, Wang, 2000). Antioxidant and 
radical scavenger properties have been described for the 
flavonoid astilbin (de la Morena, Pérez, 1999; Petacci et 
al., 2010). The increase in free radical generation has been 
implicated as one of the important mechanisms of cogni-
tive impairment. Moderate/controlled levels of oxidative 
modifications are necessary to provide the hormetic central 
underpinning of neuroprotective response (Calabrese et 
al., 2010; Mattei, et al., 2011). Thus, the results of the in 
vitro lipid peroxidation of rat homogenates suggest that 
extract BST0298 has components that inhibit the interac-
tion of free radicals with biomolecules present in the brain 
(Mattei et al., 2001). It is known that antioxidants have 
an important neuroprotective role in several neurodegen-
erative disorders such as Parkinson disease, Alzheimer 
disease, and other cognitive dysfunctions (Ng, Liu, Wang, 
2000; Moosmann, Behl, 2002). In fact, the BST0298 ex-
tract possesses a rather marked antioxidant property, which 
can contribute to its beneficial effect on memory (Mattei et 
al., 2001). However, since the extract was effective in aged 
animals which already had learning and memory deficits, 
it seems unlikely that a preventive antioxidant would be 
completely responsible for the effects of the extract.
CONCLUSION
This work shows that the hydroalcoholic extract of 
H. aphrodisiaca was effective in improving the memory of 
aged animals in a T-maze after repeated administration of 
small doses, but had no effect on the scopolamine-induced 
amnesia test. These results suggest that repeated treatment 
with H. aphrodisiaca improves learning and memory by a 
non-muscarinic mechanism. The extract presented marked 
antioxidant activity, which can contribute to its beneficial 
effect on memory.
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